Novacyt shares rise over 6% after Australian approval for chemotherapy toxicity test Shares in Novacyt SA (AIM:NCYT, OTC:NVYTF, EPA:ALNOV), the molecular diagnostics company, rose over 6% to 36.8p on Wednesday morning after its…
Novacyt shares drop 16% on legal settlement news Novacyt SAs (AIM:NCYT, OTC:NVYTF, EPA:ALNOV) share price fell 16% following the announcement of a commercial settlement in its High Court case.…